首页 > 最新文献

ASAIO transactions最新文献

英文 中文
Two-dimensional mechanical and ultrastructural correlates of bovine pericardium for prosthetic valves. 人工瓣膜用牛心包二维力学和超微结构相关性分析。
Pub Date : 1991-07-01
K X Liao, R W Frater, W Stevenson-Smith, S D Nikolic, F Macaluso, E L Yellin

Scanning electron microscopy of bovine pericardium (BP) shows anisotropic collagen fiber orientation (CFO). We studied the effect of CFO on the breaking strength of longitudinal (L) and transverse (T) strips cut from six pieces of fresh (Fr), glutaraldehyde (Glu)-, or formaldehyde (For)-fixed BP loaded at constant rate until rupture. Maximum tensile stress (Stmax) and strain (Snmax) were measured. The Stmax of L strips were larger than T ones in all groups, and Snmax was the same. Similar results were also observed in 10 pieces of Glu fixed normal canine mitral valves (MV). Maximum tensile stress is obtained when the load is parallel to CFO in both canine MV and BP.

牛心包(BP)扫描电镜显示胶原纤维取向各向异性。我们研究了CFO对从6片新鲜(Fr)、戊二醛(Glu)-或甲醛(For)-固定BP以恒定速率加载直至断裂的纵向(L)和横向(T)条剪下的断裂强度的影响。测量了最大拉伸应力(Stmax)和应变(Snmax)。各组L条的Stmax均大于T条,且Snmax相同。在10片Glu固定的正常犬二尖瓣(MV)中也观察到类似的结果。当载荷与CFO平行时,犬齿的MV和BP均获得最大拉应力。
{"title":"Two-dimensional mechanical and ultrastructural correlates of bovine pericardium for prosthetic valves.","authors":"K X Liao,&nbsp;R W Frater,&nbsp;W Stevenson-Smith,&nbsp;S D Nikolic,&nbsp;F Macaluso,&nbsp;E L Yellin","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Scanning electron microscopy of bovine pericardium (BP) shows anisotropic collagen fiber orientation (CFO). We studied the effect of CFO on the breaking strength of longitudinal (L) and transverse (T) strips cut from six pieces of fresh (Fr), glutaraldehyde (Glu)-, or formaldehyde (For)-fixed BP loaded at constant rate until rupture. Maximum tensile stress (Stmax) and strain (Snmax) were measured. The Stmax of L strips were larger than T ones in all groups, and Snmax was the same. Similar results were also observed in 10 pieces of Glu fixed normal canine mitral valves (MV). Maximum tensile stress is obtained when the load is parallel to CFO in both canine MV and BP.</p>","PeriodicalId":77493,"journal":{"name":"ASAIO transactions","volume":"37 3","pages":"M349-51"},"PeriodicalIF":0.0,"publicationDate":"1991-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12914270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Healing process of vascular prostheses seeded with venous tissue fragments. 静脉组织碎片植入血管假体的愈合过程。
Pub Date : 1991-07-01
Y Noishiki, Y Yamane, S Satoh, S Niu, T Okoshi, Y Tomizawa, C R Wildevuur

Rapid neointima formation in fabric vascular prostheses seeded with autologous venous tissue fragments was examined. A piece of peripheral vein was minced into small fragments and stirred into 20 ml of saline. This tissue suspension was sieved through the wall of Dacron prostheses. The prostheses implanted in the descending aortae of dogs showed extremely rapid healing of the neointima. Endothelial cells lined the entire luminal surface within 14 days. There was no difference in the healing process between the area near anastomotic sites and the center.

研究了自体静脉组织碎片植入织物血管假体后新生内膜的快速形成。将周围静脉切成小块,加入20ml生理盐水中搅拌。这种组织悬浮液是通过涤纶假体的壁筛选的。将假体植入犬降主动脉后,新生内膜愈合速度极快。内皮细胞在14天内排列在整个管腔表面。吻合口附近与吻合中心愈合过程无明显差异。
{"title":"Healing process of vascular prostheses seeded with venous tissue fragments.","authors":"Y Noishiki,&nbsp;Y Yamane,&nbsp;S Satoh,&nbsp;S Niu,&nbsp;T Okoshi,&nbsp;Y Tomizawa,&nbsp;C R Wildevuur","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Rapid neointima formation in fabric vascular prostheses seeded with autologous venous tissue fragments was examined. A piece of peripheral vein was minced into small fragments and stirred into 20 ml of saline. This tissue suspension was sieved through the wall of Dacron prostheses. The prostheses implanted in the descending aortae of dogs showed extremely rapid healing of the neointima. Endothelial cells lined the entire luminal surface within 14 days. There was no difference in the healing process between the area near anastomotic sites and the center.</p>","PeriodicalId":77493,"journal":{"name":"ASAIO transactions","volume":"37 3","pages":"M478-80"},"PeriodicalIF":0.0,"publicationDate":"1991-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12914275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of microsphere and intraoperative quantitation of bronchial blood flow. 微球法与术中支气管血流定量的比较。
Pub Date : 1991-07-01
R K White, R S Bliss, S D Everett, G M Pantalos, J D Marks, M Kinoshita, D B Olsen

Although significant variation in bronchial blood flow (BBF) has been reported, precise quantitation is difficult because of the small sized vessels and variable anatomy. Ventricular balance is critical to the function of the total artificial heart (TAH), and variation in BBF can alter this balance in the bovine model. Bronchial blood flow was measured in 12 calves by two methods: six by the radioactive labeled microsphere technique (MBBF), and six intraoperatively (IBBF) during cardiopulmonary bypass (CPB). In the MBBF group, BBF ranged from 1.9 ml/kg to 16.0 ml/kg, whereas IBBF varied from 2.6 ml/kg to 10 ml/kg (NS). Cardiac output (CO) was significantly higher (p less than 0.0005) in the MBBF group. Bronchial blood flow in both groups was highly variable. The higher flow in the MBBF group may be attributed to the arteriovenous shunting of microspheres, whereas lower flow in the IBBF group may be secondary to physiologic changes during CPB. This technique, described to measure IBBF, can estimate large variations in the natural right to left shunt that contributes to imbalance in the TAH.

虽然有报道支气管血流量(BBF)有显著变化,但由于血管小且解剖结构多变,难以精确定量。心室平衡对全人工心脏(TAH)的功能至关重要,血流量的变化可以改变牛模型中的这种平衡。采用放射性标记微球技术(MBBF)和体外循环(CPB)术中(IBBF)两种方法测量了12头小牛的支气管血流量。在MBBF组,BBF范围为1.9 ml/kg至16.0 ml/kg,而IBBF范围为2.6 ml/kg至10 ml/kg (NS)。心输出量(CO)显著高于MBBF组(p < 0.0005)。两组的支气管血流量变化很大。MBBF组较高的血流可能归因于微球的动静脉分流,而IBBF组较低的血流可能继发于CPB期间的生理变化。该技术用于测量IBBF,可以估计导致TAH失衡的自然右至左分流的大变化。
{"title":"Comparison of microsphere and intraoperative quantitation of bronchial blood flow.","authors":"R K White,&nbsp;R S Bliss,&nbsp;S D Everett,&nbsp;G M Pantalos,&nbsp;J D Marks,&nbsp;M Kinoshita,&nbsp;D B Olsen","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Although significant variation in bronchial blood flow (BBF) has been reported, precise quantitation is difficult because of the small sized vessels and variable anatomy. Ventricular balance is critical to the function of the total artificial heart (TAH), and variation in BBF can alter this balance in the bovine model. Bronchial blood flow was measured in 12 calves by two methods: six by the radioactive labeled microsphere technique (MBBF), and six intraoperatively (IBBF) during cardiopulmonary bypass (CPB). In the MBBF group, BBF ranged from 1.9 ml/kg to 16.0 ml/kg, whereas IBBF varied from 2.6 ml/kg to 10 ml/kg (NS). Cardiac output (CO) was significantly higher (p less than 0.0005) in the MBBF group. Bronchial blood flow in both groups was highly variable. The higher flow in the MBBF group may be attributed to the arteriovenous shunting of microspheres, whereas lower flow in the IBBF group may be secondary to physiologic changes during CPB. This technique, described to measure IBBF, can estimate large variations in the natural right to left shunt that contributes to imbalance in the TAH.</p>","PeriodicalId":77493,"journal":{"name":"ASAIO transactions","volume":"37 3","pages":"M507-9"},"PeriodicalIF":0.0,"publicationDate":"1991-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12914279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nafamostat mesilate administration during cardiopulmonary bypass decreases postoperative bleeding after cardiac surgery. 体外循环期间给予甲磺酸那莫他可减少心脏手术后出血。
Pub Date : 1991-07-01
T Sato, K Tanaka, C Kondo, T Morimoto, I Yada, H Yuasa, M Kusagawa, K Deguchi

The hemostatic effect of nafamostat mesilate (FUT-175) was evaluated in patients undergoing cardiopulmonary bypass (CPB) surgery. Thirty patients undergoing aortocoronary bypass grafting were divided into two groups. In the control group, anticoagulation was achieved with an initial dose of heparin (3 mg/kg). In the FUT-175-treated group, in addition to the ordinary treatment with heparin, FUT-175 was infused continuously into the circuit throughout the procedure at a rate of 100 mg/hr. Thrombin-antithrombin III complex (TAT), fibrinopeptide A (FPA), and fibrin degradation products (FDP-D) dimer increased in both groups as CPB proceeded. In the FUT-175-treated group, these parameters remained lower and decreased more rapidly after the end of CPB. Alpha 2 plasmin inhibitor/plasmin complex (PIC) increased progressively during CPB in the control group; no such significant increases were seen in the FUT-175-treated group. Postoperative blood loss was significantly lower in the FUT-175-treated group than in the control group. It was concluded that FUT-175 reduces postoperative blood loss by inhibiting both coagulation and fibrinolysis during CPB.

评价了甲磺酸那莫他酯(FUT-175)在体外循环(CPB)手术患者中的止血效果。将30例行冠状动脉旁路移植术的患者分为两组。在对照组中,初始剂量为肝素(3mg /kg)实现抗凝。在FUT-175治疗组中,除了普通肝素治疗外,FUT-175在整个过程中以100 mg/hr的速率连续输注到回路中。随着CPB的进行,两组的凝血酶-抗凝血酶III复合物(TAT)、纤维蛋白肽A (FPA)和纤维蛋白降解产物(FDP-D)二聚体均增加。在fut -175治疗组,这些参数在CPB结束后保持较低且下降更快。对照组CPB期间α - 2纤溶酶抑制剂/纤溶酶复合体(PIC)逐渐升高;fut -175治疗组未见明显升高。fut -175治疗组术后出血量明显低于对照组。结论FUT-175通过抑制CPB期间的凝血和纤溶来减少术后失血量。
{"title":"Nafamostat mesilate administration during cardiopulmonary bypass decreases postoperative bleeding after cardiac surgery.","authors":"T Sato,&nbsp;K Tanaka,&nbsp;C Kondo,&nbsp;T Morimoto,&nbsp;I Yada,&nbsp;H Yuasa,&nbsp;M Kusagawa,&nbsp;K Deguchi","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The hemostatic effect of nafamostat mesilate (FUT-175) was evaluated in patients undergoing cardiopulmonary bypass (CPB) surgery. Thirty patients undergoing aortocoronary bypass grafting were divided into two groups. In the control group, anticoagulation was achieved with an initial dose of heparin (3 mg/kg). In the FUT-175-treated group, in addition to the ordinary treatment with heparin, FUT-175 was infused continuously into the circuit throughout the procedure at a rate of 100 mg/hr. Thrombin-antithrombin III complex (TAT), fibrinopeptide A (FPA), and fibrin degradation products (FDP-D) dimer increased in both groups as CPB proceeded. In the FUT-175-treated group, these parameters remained lower and decreased more rapidly after the end of CPB. Alpha 2 plasmin inhibitor/plasmin complex (PIC) increased progressively during CPB in the control group; no such significant increases were seen in the FUT-175-treated group. Postoperative blood loss was significantly lower in the FUT-175-treated group than in the control group. It was concluded that FUT-175 reduces postoperative blood loss by inhibiting both coagulation and fibrinolysis during CPB.</p>","PeriodicalId":77493,"journal":{"name":"ASAIO transactions","volume":"37 3","pages":"M194-5"},"PeriodicalIF":0.0,"publicationDate":"1991-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12914330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of postoperative biventricular failure by means of a right ventricular assist device and an intraaortic balloon pump. 应用右心室辅助装置和主动脉内球囊泵治疗术后双心室功能衰竭。
Pub Date : 1991-07-01
T Shimizu, H Sasaki, S Sakamoto, Y Kaneto, T Akutsu

Right dominant biventricular failure often accompanies the end-stage of combined rheumatic valvular disease and some kinds of congenital heart disease. The management of right ventricular failure with conventional medical treatment, however, has encountered many difficulties. Mechanical support of the right ventricle with an RVAD (right ventricular assist device) has proved useful and effective. Seven patients who could not be weaned from cardiopulmonary bypass were subsequently transferred to an intraaortic balloon pump (IABP) and RVAD. Among these, five had severe combined rheumatic valvular disease, one had congenital heart disease and was advanced in age, and the other had a left atrial myxoma with tricuspid regurgitation. Preoperatively, all of these patients had had biventricular failure. All seven cases were successfully weaned from RVAD, and later from IABP. Five patients were discharged from the hospital and returned to normal daily life. Two patients died during their postoperative course. Long-term survival rate was 71%. Mechanical assist with RVAD and IABP seemed to be effective in the management of right dominant biventricular failure, such as that seen in combined valvular disease and some kinds of congenital heart disease.

风湿性瓣膜病和某些先天性心脏病的终末期常伴有右侧显性双心室衰竭。然而,传统医学治疗右心衰的管理遇到了许多困难。机械支持右心室与RVAD(右心室辅助装置)已被证明是有用的和有效的。7例不能脱离体外循环的患者随后被转移到主动脉内球囊泵(IABP)和RVAD。其中5例合并严重风湿性心瓣膜病,1例患有先天性心脏病高龄,1例左心房黏液瘤合并三尖瓣反流。术前,所有患者均有双心室功能衰竭。所有7例均成功脱离RVAD,随后又脱离IABP。5名患者出院,恢复正常生活。2例患者在术后死亡。长期生存率为71%。机械辅助与RVAD和IABP似乎是有效的管理右优势双心室衰竭,如在合并瓣膜疾病和某些类型的先天性心脏病。
{"title":"Management of postoperative biventricular failure by means of a right ventricular assist device and an intraaortic balloon pump.","authors":"T Shimizu,&nbsp;H Sasaki,&nbsp;S Sakamoto,&nbsp;Y Kaneto,&nbsp;T Akutsu","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Right dominant biventricular failure often accompanies the end-stage of combined rheumatic valvular disease and some kinds of congenital heart disease. The management of right ventricular failure with conventional medical treatment, however, has encountered many difficulties. Mechanical support of the right ventricle with an RVAD (right ventricular assist device) has proved useful and effective. Seven patients who could not be weaned from cardiopulmonary bypass were subsequently transferred to an intraaortic balloon pump (IABP) and RVAD. Among these, five had severe combined rheumatic valvular disease, one had congenital heart disease and was advanced in age, and the other had a left atrial myxoma with tricuspid regurgitation. Preoperatively, all of these patients had had biventricular failure. All seven cases were successfully weaned from RVAD, and later from IABP. Five patients were discharged from the hospital and returned to normal daily life. Two patients died during their postoperative course. Long-term survival rate was 71%. Mechanical assist with RVAD and IABP seemed to be effective in the management of right dominant biventricular failure, such as that seen in combined valvular disease and some kinds of congenital heart disease.</p>","PeriodicalId":77493,"journal":{"name":"ASAIO transactions","volume":"37 3","pages":"M339-40"},"PeriodicalIF":0.0,"publicationDate":"1991-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12914339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dynamic internal compliance of a vascular prosthesis. 血管假体的动态内部顺应性。
Pub Date : 1991-07-01
R Tu, J McIntyre, C Hata, C L Lu, E Wang, R C Quijano

A new technique was used to measure dynamic internal compliance of a blood vessel or vascular graft subjected to dynamic internal pressure. The internal compliance can be broken into three categories: the volumetric compliance (CV), defined as (dV/V)/dP; the longitudinal compliance (CL), defined as (dL/L)/dP; and radial compliance (CR), defined as (dR/R)/dP. It can be shown mathematically that CV = 2 CR + CL. Thus, measuring any two of the three entities will also give the value for the third. A Dynatek DCT1 dynamic compliance tester was used for measuring the compliance of DenaflexTM biologic grafts and fresh bovine internal thoracic arteries, from which the Denaflex grafts were obtained by fixation. Volumetric compliance was obtained with the test sample mounted in a loose loop that allowed the sample to move both radially and longitudinally. By mounting the sample in a straight fashion that limited longitudinal movement, the radial compliance was determined. The longitudinal compliance was then calculated from the above relationship. Test results show that the fresh bovine artery had an average volumetric compliance of 26.1%/100 mmHg, radial compliance of 9.5%/100 mmHg, and longitudinal compliance of 7.2%/100 mmHg. The Denaflex vascular graft showed a reduction in longitudinal and radial compliance, compared to the fresh raw artery, as a result of extensive fixation.

本文提出了一种测量血管或血管移植物在动态内压作用下动态内顺应性的新方法。内部顺应性可分为三类:体积顺应性(CV),定义为(dV/V)/dP;纵向顺应度(CL),定义为(dL/L)/dP;径向柔度(CR),定义为(dR/R)/dP。CV = 2cr + CL可以用数学方法表示。因此,测量三个实体中的任意两个也会得到第三个实体的值。采用Dynatek DCT1型动态顺应性测试仪测量DenaflexTM生物移植物与新鲜牛胸内动脉的顺应性,固定获得Denaflex移植物。体积顺应性与测试样品安装在一个松散的环路,允许样品径向和纵向移动。通过以限制纵向运动的直线方式安装样品,确定了径向顺应性。然后根据上述关系计算纵向柔度。实验结果表明,牛新鲜动脉的平均体积顺应性为26.1%/100 mmHg,径向顺应性为9.5%/100 mmHg,纵向顺应性为7.2%/100 mmHg。与新鲜的生动脉相比,由于广泛的固定,Denaflex血管移植物显示出纵向和径向顺应性的降低。
{"title":"Dynamic internal compliance of a vascular prosthesis.","authors":"R Tu,&nbsp;J McIntyre,&nbsp;C Hata,&nbsp;C L Lu,&nbsp;E Wang,&nbsp;R C Quijano","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A new technique was used to measure dynamic internal compliance of a blood vessel or vascular graft subjected to dynamic internal pressure. The internal compliance can be broken into three categories: the volumetric compliance (CV), defined as (dV/V)/dP; the longitudinal compliance (CL), defined as (dL/L)/dP; and radial compliance (CR), defined as (dR/R)/dP. It can be shown mathematically that CV = 2 CR + CL. Thus, measuring any two of the three entities will also give the value for the third. A Dynatek DCT1 dynamic compliance tester was used for measuring the compliance of DenaflexTM biologic grafts and fresh bovine internal thoracic arteries, from which the Denaflex grafts were obtained by fixation. Volumetric compliance was obtained with the test sample mounted in a loose loop that allowed the sample to move both radially and longitudinally. By mounting the sample in a straight fashion that limited longitudinal movement, the radial compliance was determined. The longitudinal compliance was then calculated from the above relationship. Test results show that the fresh bovine artery had an average volumetric compliance of 26.1%/100 mmHg, radial compliance of 9.5%/100 mmHg, and longitudinal compliance of 7.2%/100 mmHg. The Denaflex vascular graft showed a reduction in longitudinal and radial compliance, compared to the fresh raw artery, as a result of extensive fixation.</p>","PeriodicalId":77493,"journal":{"name":"ASAIO transactions","volume":"37 3","pages":"M470-2"},"PeriodicalIF":0.0,"publicationDate":"1991-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12914346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A multicenter study of short hour dialysis using AN69S. Preliminary results. AN69S用于短小时透析的多中心研究。初步结果。
Pub Date : 1991-07-01
R M Lindsay, E Spanner, A P Heidenheim, H Burton, S Lindsay, J M LeFebvre

A multicenter prospective study of short hour (SH, less than or equal to 3 hr) dialysis using a high flux membrane (AN69S) plus volumetric control (VC), versus conventional (greater than or equal to 4 hr) (CNV) cellulosic non-VC dialysis, is ongoing. The study hypothesizes that SH treatment over 1 year will provide adequate dialysis, will not increase morbidity, and may improve quality of life. To date, 112 patients have been entered, and 54 have completed 6 months, 30 by SH. There were no differences in biophysiologic parameters at 6 months. Mean hospitalization was 5.24 days per patient. The SH group had a higher (p = 0.0374) hospitalization rate because of two patients. Quality of life was similar in SH and CNV groups. The study indicates that SH dialysis is feasible, safe, and as comfortable as CNV.

目前正在进行一项多中心前瞻性研究,将使用高通量膜(AN69S)加容量控制(VC)的短小时(SH,小于或等于3小时)透析与传统(大于或等于4小时)(CNV)纤维素非VC透析进行对比。该研究假设,1年以上的SH治疗将提供足够的透析,不会增加发病率,并可能改善生活质量。迄今为止,已有112例患者入组,其中54例完成6个月,30例完成SH。6个月时生物生理参数无差异。平均住院5.24天。SH组有2例患者,住院率较高(p = 0.0374)。SH组和CNV组的生活质量相似。该研究表明SH透析是可行的、安全的,并且与CNV一样舒适。
{"title":"A multicenter study of short hour dialysis using AN69S. Preliminary results.","authors":"R M Lindsay,&nbsp;E Spanner,&nbsp;A P Heidenheim,&nbsp;H Burton,&nbsp;S Lindsay,&nbsp;J M LeFebvre","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A multicenter prospective study of short hour (SH, less than or equal to 3 hr) dialysis using a high flux membrane (AN69S) plus volumetric control (VC), versus conventional (greater than or equal to 4 hr) (CNV) cellulosic non-VC dialysis, is ongoing. The study hypothesizes that SH treatment over 1 year will provide adequate dialysis, will not increase morbidity, and may improve quality of life. To date, 112 patients have been entered, and 54 have completed 6 months, 30 by SH. There were no differences in biophysiologic parameters at 6 months. Mean hospitalization was 5.24 days per patient. The SH group had a higher (p = 0.0374) hospitalization rate because of two patients. Quality of life was similar in SH and CNV groups. The study indicates that SH dialysis is feasible, safe, and as comfortable as CNV.</p>","PeriodicalId":77493,"journal":{"name":"ASAIO transactions","volume":"37 3","pages":"M465-7"},"PeriodicalIF":0.0,"publicationDate":"1991-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12914348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Catheter with an anchoring tip for chronic joint capsule perfusion. 带锚定尖端的导管用于慢性关节囊灌注。
Pub Date : 1991-07-01
B D Wigness, F D Dorman, H J Robinson, E A Arendt, T R Oegema, T D Rohde, H Buchwald

An orthopedic catheter for long-term access to the synovial joint is anchored by a hollow threaded tap that penetrates the capsule through a hole drilled in the surrounding bone. The proximal end of the catheter is connected to either an implantable drug infusion pump or an implantable access port for continuous or intermittent perfusion or sampling. Four catheters were evaluated in dogs. Three were attached to ports, the fourth to a pump. Water (one trial, 22 weeks) and hyaluronic acid (HA) (5 mg/ml; two trials of 8 weeks each) were administered through ports twice weekly in 1.5 ml boluses; 5 mg/ml HA was delivered by pump (1 trial of 33 weeks) at 0.31 ml/day.

长期进入滑膜关节的矫形导管由一个空心螺纹丝锥固定,该丝锥通过在周围骨上钻的孔穿透囊。所述导管近端连接可植入药物输注泵或可植入接入端口,用于连续或间歇灌注或取样。在犬中评估了4个导管。其中三个连接在端口上,第四个连接在泵上。水(1次试验,22周)和透明质酸(HA) (5 mg/ml;两项试验(每次8周)通过端口给药,每周两次,每次1.5 ml;以0.31 ml/天的剂量泵送HA 5 mg/ml(33周1次)。
{"title":"Catheter with an anchoring tip for chronic joint capsule perfusion.","authors":"B D Wigness,&nbsp;F D Dorman,&nbsp;H J Robinson,&nbsp;E A Arendt,&nbsp;T R Oegema,&nbsp;T D Rohde,&nbsp;H Buchwald","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>An orthopedic catheter for long-term access to the synovial joint is anchored by a hollow threaded tap that penetrates the capsule through a hole drilled in the surrounding bone. The proximal end of the catheter is connected to either an implantable drug infusion pump or an implantable access port for continuous or intermittent perfusion or sampling. Four catheters were evaluated in dogs. Three were attached to ports, the fourth to a pump. Water (one trial, 22 weeks) and hyaluronic acid (HA) (5 mg/ml; two trials of 8 weeks each) were administered through ports twice weekly in 1.5 ml boluses; 5 mg/ml HA was delivered by pump (1 trial of 33 weeks) at 0.31 ml/day.</p>","PeriodicalId":77493,"journal":{"name":"ASAIO transactions","volume":"37 3","pages":"M290-2"},"PeriodicalIF":0.0,"publicationDate":"1991-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12914543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Percutaneous transluminal coronary angioplasty with hemoperfusion. 经皮腔内冠状动脉成形术伴血液灌流。
Pub Date : 1991-07-01
R Snyder, B Wijay, P Angelini

Balloon inflation time during percutaneous transluminal coronary angioplasty (PTCA) is limited by the patient's tolerance to ischemia. A nonpulsatile, variable flow rate syringe pump that develops pressures up to 200 psi has been developed, along with PTCA catheters capable of delivering 0-70 cc/min of blood across a lesion at these pressures. Using this system, 110 patients have been treated with active hemoperfusion during routine PTCA. In eight cases, no preperfusion tolerated inflation time was obtained. In 96 of 102 cases, the tolerated inflation time was increased by at least 50%, for a success rate of 94%. This study demonstrated that active hemoperfusion during PTCA prolongs tolerated inflation time. The catheters and pump are capable of performing routine PTCA, supported when necessary by active hemoperfusion.

经皮冠状动脉腔内成形术(PTCA)中球囊膨胀时间受患者对缺血耐受性的限制。一种压力可达200psi的无脉动、可变流量注射泵已经开发出来,同时PTCA导管能够在这些压力下通过病变输送0- 70cc /min的血液。使用该系统,110例患者在常规PTCA中接受主动血液灌流治疗。8例未获得灌注前耐受充气时间。102例患者中,96例患者的可容忍膨胀时间至少增加了50%,成功率为94%。本研究表明,PTCA期间的主动血液灌流延长了耐受膨胀时间。导管和泵能够执行常规PTCA,必要时通过主动血液灌流支持。
{"title":"Percutaneous transluminal coronary angioplasty with hemoperfusion.","authors":"R Snyder,&nbsp;B Wijay,&nbsp;P Angelini","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Balloon inflation time during percutaneous transluminal coronary angioplasty (PTCA) is limited by the patient's tolerance to ischemia. A nonpulsatile, variable flow rate syringe pump that develops pressures up to 200 psi has been developed, along with PTCA catheters capable of delivering 0-70 cc/min of blood across a lesion at these pressures. Using this system, 110 patients have been treated with active hemoperfusion during routine PTCA. In eight cases, no preperfusion tolerated inflation time was obtained. In 96 of 102 cases, the tolerated inflation time was increased by at least 50%, for a success rate of 94%. This study demonstrated that active hemoperfusion during PTCA prolongs tolerated inflation time. The catheters and pump are capable of performing routine PTCA, supported when necessary by active hemoperfusion.</p>","PeriodicalId":77493,"journal":{"name":"ASAIO transactions","volume":"37 3","pages":"M367-8"},"PeriodicalIF":0.0,"publicationDate":"1991-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12914793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcome of cardiopulmonary resuscitation in patients on chronic dialysis. 慢性透析患者心肺复苏的结果。
Pub Date : 1991-07-01
A H Tzamaloukas, G H Murata, P S Avasthi

The authors analyzed the outcome of 56 episodes of cardiopulmonary resuscitation (CPR) in dialysis patients. Eleven patients (20%) left the hospital alive. Univariate analysis showed that a functional cause of cardiac arrest, absence of rib fractures, and the occurrence of cardiac arrest in the dialysis or intensive care units were associated with a favorable outcome. Logistic regression showed that the outcome of CPR was related to the presence of rib fractures, cause of arrest, degree of preexisting heart disease, and patient age. Despite the high incidence of rib fractures (77%), the outcome of CPR in dialysis patients is similar to its outcome in the general population.

作者分析了56次透析患者心肺复苏(CPR)的结果。11名患者(20%)活着出院。单因素分析显示,心脏骤停的功能性原因、没有肋骨骨折以及透析或重症监护病房中心脏骤停的发生与有利的结果相关。Logistic回归显示心肺复苏术的结果与肋骨骨折、骤停原因、既往心脏病程度和患者年龄有关。尽管肋骨骨折的发生率很高(77%),透析患者心肺复苏的结果与普通人群相似。
{"title":"Outcome of cardiopulmonary resuscitation in patients on chronic dialysis.","authors":"A H Tzamaloukas,&nbsp;G H Murata,&nbsp;P S Avasthi","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The authors analyzed the outcome of 56 episodes of cardiopulmonary resuscitation (CPR) in dialysis patients. Eleven patients (20%) left the hospital alive. Univariate analysis showed that a functional cause of cardiac arrest, absence of rib fractures, and the occurrence of cardiac arrest in the dialysis or intensive care units were associated with a favorable outcome. Logistic regression showed that the outcome of CPR was related to the presence of rib fractures, cause of arrest, degree of preexisting heart disease, and patient age. Despite the high incidence of rib fractures (77%), the outcome of CPR in dialysis patients is similar to its outcome in the general population.</p>","PeriodicalId":77493,"journal":{"name":"ASAIO transactions","volume":"37 3","pages":"M369-70"},"PeriodicalIF":0.0,"publicationDate":"1991-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12914794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
ASAIO transactions
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1